Overview

Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disease

Status:
Not yet recruiting

Trial end date:
2025-01-15

Target enrollment:

Participant gender:

Summary

The purpose of this study is to learn about the safety and side effects of intralesional collagenase clostridium histolyticum (CCH) injected into the Peyronies Disease (PD) plaque after receiving prior treatment with intralesional Platelet Rich Plasma (PRP) injections.

Phase:

Phase 4

Details

Lead Sponsor:

University of Miami

Collaborator:

Endo Pharmaceuticals